Grant: Operating Grant - PA: INMD Start-up Funds (Clinicians and New Investigators)
University of Guelph
$100,000.00
FADS2 modulates n-3 fatty acid regulation of adipose tissue inflammation.
FY 2013-14
Summary
Type 2 diabetes (T2D) and cardiovascular disease (CVD) are two of the most serious public health concerns affecting Canadians. A common feature of both diseases is an increase in fat tissue inflammation. Therefore drug and lifestyle therapies that reduce fat tissue inflammation will help decrease an individual's risk for T2D and/or CVD. While drugs can help to treat or slow the development of these diseases, they don't always work and can sometimes cause harmful side effects. In comparison, changing a person's diet can be a safe and effective way to help prevent and treat these diseases. Consuming omega-3 fatty acids (FAs) is highly encouraged because of their benefits for health and development. Two omega-3 FAs (eicosapentaenoic acid, EPA; docosahexaenoic acid, DHA) are of particular interest because they reduce fat tissue inflammation. EPA and DHA can be obtained by consuming fatty fish or they can be produced to a limited extent by our body. Recent evidence has shown that the genes involved in the production of EPA and DHA in our body differ between people. This affects how much of these FAs a person is able to produce. In other words, some people are "high" producers of EPA and DHA, and others are "low" producers. Because "high" producers will have more EPA and DHA, it is assumed that they will have less fat tissue inflammation compared to "low" producers; however, this has not been proven yet. The goal of this research is to study the genes controlling EPA and DHA production in fat tissue using both mice and humans. This project will improve our understanding of these genes in fat tissue and generate strong support to use these FAs as a way to prevent and treat common diseases.
Department
Program
Operating Grant - PA: INMD Start-up Funds (Clinicians and New Investigators)
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
310275
Name
Mutch David M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Nutrition, Food & Health
Projecttitle
FADS2 modulates n-3 fatty acid regulation of adipose tissue inflammation.
Programtype2
Operating Grants
Orgnameinp2
University of Guelph
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: INMD Start-up Funds (Clinicians and New Investigators)
Keyworddelim
Adipokines; Adipose Tissue; Clinical Study; Eicosanoids; Fatty Acid Desaturase 2; Inflammation; Knock-Out Mouse Model; Microarray; N-3 Fatty Acids; Translational Research
Abstract
Type 2 diabetes (T2D) and cardiovascular disease (CVD) are two of the most serious public health concerns affecting Canadians. A common feature of both diseases is an increase in fat tissue inflammation. Therefore drug and lifestyle therapies that reduce fat tissue inflammation will help decrease an individual's risk for T2D and/or CVD. While drugs can help to treat or slow the development of these diseases, they don't always work and can sometimes cause harmful side effects. In comparison, changing a person's diet can be a safe and effective way to help prevent and treat these diseases. Consuming omega-3 fatty acids (FAs) is highly encouraged because of their benefits for health and development. Two omega-3 FAs (eicosapentaenoic acid, EPA; docosahexaenoic acid, DHA) are of particular interest because they reduce fat tissue inflammation. EPA and DHA can be obtained by consuming fatty fish or they can be produced to a limited extent by our body. Recent evidence has shown that the genes involved in the production of EPA and DHA in our body differ between people. This affects how much of these FAs a person is able to produce. In other words, some people are "high" producers of EPA and DHA, and others are "low" producers. Because "high" producers will have more EPA and DHA, it is assumed that they will have less fat tissue inflammation compared to "low" producers; however, this has not been proven yet. The goal of this research is to study the genes controlling EPA and DHA production in fat tissue using both mice and humans. This project will improve our understanding of these genes in fat tissue and generate strong support to use these FAs as a way to prevent and treat common diseases.
Competitiondate
201403
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mutch, David M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~